Herbas VPB

Print
EN | LT
LT - 5’-Adenozindifosfato ribozės (ADPR) medicininis panaudojimas
EN - MEDICAL USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/7076 (2006.01)
A61K 31/522 (2006.01)
A61K 31/675 (2006.01)
A61K 33/24 (2019.01)
A61K 45/06 (2006.01)
C07H 19/20 (2006.01)
A61P 31/20 (2006.01)
A61P 35/00 (2006.01)
A61P 27/02 (2006.01)
A61P 11/00 (2006.01)
A61P 29/00 (2006.01)
European patent
(11) Number of the document 3416654
(13) Kind of document T
(96) European patent application number 17708104.9
Date of filing the European patent application 2017-02-17
(97) Date of publication of the European application 2018-12-26
(45) Date of publication and mention of the grant of the patent 2021-10-27
(46) Date of publication of the claims translation 2022-01-10
PCT application
(86) Number PCT/US2017/018253
Date 2017-02-17
PCT application publication
(87) Number WO 2017/143113
Date 2017-08-24
Priority applications
(30) Number Date Country code
201662296665 P 2016-02-18 US
201662428721 P 2016-12-01 US
Inventors
(72)
SHALWITZ, Robert , US
Grantee
(73) Invirsa, Inc. , 1275 Kinnear Road, Columbus OH 43212, US
Attorney or representative
(74) Aušra PAKĖNIENĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) 5’-Adenozindifosfato ribozės (ADPR) medicininis panaudojimas
  MEDICAL USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)
Last renewal fee
Payment date Validity (years) Amount
2025-01-23 9 208.00 EUR
Next renewal fee
2026-02-17